Foghorn Therapeutics Inc.
FHTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001822462
No open-market purchases or sales by Foghorn Therapeutics Inc. insiders were filed in the last 90 days; 102 institutions reported holding it in 13F filings for Q2 2026, worth $219.2M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Foghorn Therapeutics Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 39 | 47 | +8 |
| Shares | 23.9M | 24.3M | +371.9K (+1.6%) |
| Value | $255.1M | $338.2M | +$83.1M (+32.6%) |
New holders (11)
Institutions that held Foghorn Therapeutics Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Kingdon Capital Management, L.L.C. | 205,741 | $2.87M | 0.50% |
| Pura Vida Investments, LLC | 68,095 | $949.0K | 0.07% |
| J. Goldman & Co LP | 67,500 | $940.0K | 0.08% |
| Goldman Sachs Group Inc | 12,809 | $178.0K | 0.00% |
| SG Americas Securities, LLC | 10,925 | $152.0K | 0.00% |
| MetLife Investment Management | 8,683 | $121.0K | 0.00% |
| Metropolitan Life Insurance Co | 6,569 | $91.5K | 0.00% |
| Advisor Group Holdings, Inc. | 750 | $10.0K | 0.00% |
| US Bancorp | 73 | $1.00K | 0.00% |
| Quadrant Capital Group LLC | 89 | $1.00K | 0.00% |
| Ellevest, Inc. | 4 | $0 | 0.00% |
Sold out (3)
Institutions that held Foghorn Therapeutics Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| NewSquare Capital LLC | 5,000 | $53.0K |
| Signaturefd, LLC | 76 | $1.00K |
| Wells Fargo & Company | 38 | $0 |